Huong Tu Lam

Ms. Huong Tu Lam

Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Hồ Chí Minh, Vietnam
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2024 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
Thong Duy VoThong Duy Vo
Thong Duy Vo
VBVan Thi Thu Bui
Van Thi Thu Bui
Huong Tu LamHuong Tu Lam
Huong Tu Lam
QBQuynh Thi Huong Bui
Quynh Thi Huong Bui
Direct‐acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) treatment through their high cure rates and improved safety profiles. We aimed to evaluate the efficacy and safety, and identify the optimal combination, of DAAs for the treatment of chronic HCV. A retrospective study was conducted of 613 patients with chronic HCV who were treated with DAAs. Demographic, HCV genotype, treatment regimen, virological response, and adverse drug event (ADE) data were collected at the initial visit and 4, 8, 12, and 24 weeks later. The rapid virologic response (RVR) and sustained virologic response (SVR) rates were 90.4% and 97.8% for HCV genotype 1, 89.2% and 98.7% for genotype 6, 92.8% and 99% for genotype 2, and 90.9% and 100% for mixed genotype 2/6 or unspecified genotypes, respectively. There were no significant differences in the RVR and SVR rates for the various DAA regimens. The mean ALT, AST, and GGT activities decreased, and the PLT count increased during the treatments. ADEs occurred in 8% of the patients. The commonest ADEs were itching (3.1%), fatigue (1.8%), and dizziness (1.1%). None of the patients discontinued treatment because of an ADE. Posttreatment disease progression occurred in 7.7% of the patients, including liver fibrosis (3.6%), cirrhosis (1.1%), hepatocellular carcinoma (1.1%), and high alpha‐fetoprotein (AFP) (1%). The factors associated with the achievement of RVR were low viral load, the use of sofosbuvir/ledipasvir or sofosbuvir/daclatasvir regimens, and a treatment duration of 12 weeks. No specific factors were found to be associated with the achievement of SVR. Posttreatment disease progression was associated with a high AFP and the use of sofosbuvir/ledipasvir. Thus, DAAs are highly effective and well‐tolerated means of treating chronic HCV, and significantly improve patient outcomes. Their high efficacy and favorable safety profiles highlight the importance of early diagnosis and the use of personalized treatment strategies.

1 July 2024 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
Huong Tu LamHuong Tu Lam
Huong Tu Lam
TNThang Dinh Nguyen
Thang Dinh Nguyen
HBHoang Huu Bui
Hoang Huu Bui
Thong Duy VoThong Duy Vo
Thong Duy Vo
Introduction: The Charlson Comorbidity Index ≥ 2, in-Hospital onset, Albumin < 2.5 g/dL, altered Mental status, Eastern Cooperative Oncology Group Performance status ≥ 2, Steroid use (CHAMPS) score is a novel and promising prognostic tool. We present an initial external validation of the CHAMPS score for predicting mortality in acute nonvariceal upper gastrointestinal bleeding (NVUGIB) across multiple clinical outcomes. Methods: A prospective cohort study was conducted on adult patients with NVUGIB admitted to the Department of Gastroenterology between November 2022 and June 2023. The CHAMPS score performance in predicting in-hospital outcomes was evaluated by employing area under the receiver operating characteristic (AUROC) curves, followed by a comparative analysis with five pre-existing scores. Results: A total of 140 patients were included in the study. The CHAMPS score showed its highest performance in predicting mortality rates (AUROC = 0.89), significantly outperforming the Glasgow-Blatchford Bleeding Score (GBS) as well as the Albumin level < 3.0 mg/dL, International normalized ratio > 1.5, altered Mental status, Systolic blood pressure ≤ 90 mmHg, and age > 65 years (AIMS65) score (AUROC = 0.72 and 0.71, respectively; all p < 0.05). Subgroup analysis for bleeding-related and non-bleeding-related mortality further confirmed the robust predictive capability of the CHAMPS score (AUROC = 0.88 and 0.87, respectively). The CHAMPS score failed to predict rebleeding and intervention reliably, exhibiting AUROC values of 0.43 and 0.55, respectively. The optimal CHAMPS score cutoff value for predicting mortality was 3 points, achieving 100% sensitivity and 71.2% specificity. In the low-risk category defined by both CHAMPS and GBS scores, mortality and rebleeding rates were 0%. However, within the CHAMPS score-based low-risk group, 58.8% required intervention, contrasting with a 0% intervention rate for the GBS score-based low-risk group (GBS score ≤ 1). Conclusion: The CHAMPS score consistently demonstrated a robust predictive performance for mortality (AUROC > 0.8), facilitating the identification of high-risk patients requiring aggressive treatment and low-risk patients in need of localized treatment or safe discharge after successful bleeding control.

15 May 2024 in Cureus
Verified
Journal Article
Open access
PDF file
TPTram N. Pham
Tram N. Pham
QNQui H. Nguyen
Qui H. Nguyen
Huong Tu LamHuong Tu Lam
Huong Tu Lam
TNThang D. Nguyen
Thang D. Nguyen
Thong Duy VoThong Duy Vo
Thong Duy Vo
Foreign body-related complications are rare but possibly fatal events in clinical practice. Liver abscess as a result of gastrointestinal perforation caused by foreign bodies is even more rare. We report a case of a 63-year-old man who was admitted with fever and left epigastric pain. Further investigation revealed a liver abscess without resolution despite antibiotic therapy for several weeks. In the second admission, an enhanced computerized tomography scan revealed multiple abscesses in the left lobe of the liver, with a linear radio-dense foreign body within the collection. Open surgery was performed to extract the foreign body. The patient made a satisfactory postoperative recovery without complications and was discharged on the sixth postoperative day.

1 November 2024 in Journal of Clinical Gastroenterology
Verified
Journal Article
Open access
Thong Duy VoThong Duy Vo
Thong Duy Vo
SMSang Hoai Md Mai
Sang Hoai Md Mai
Huong Tu LamHuong Tu Lam
Huong Tu Lam
Introduction: Early diagnosis of hepatocellular carcinoma (HCC) is crucial but challenging, and late detection limits its treatment and prognosis. We aimed to evaluate the GALAD score as a novel yet highly accurate and promising diagnostic tool for HCC. Methods: A prospective and retrospective cohort study was conducted in 196 adult patients with cirrhosis, including 102 with HCC and 94 without. The diagnostic performance of the GALAD score for HCC detection was compared with that of single biomarkers. Results: In patients with cirrhosis with HCC, the GALAD score was 2.5 (95% CI: −2.43 to 11.09), which was significantly higher than the GALAD score of −2.46 (95% CI: −6.15 to 2.04) in patients with cirrhosis without HCC (P<0.001). Patients with multiple tumors had a significantly higher GALAD score than those with a single tumor (P=0.0081). There was a moderate correlation between the GALAD score and tumor size in patients with cirrhosis (r=0.44; P<0.001). The GALAD score had an area under the receiver operating characteristic curve of 0.91, higher than that of all single biomarkers used to diagnose HCC (all P<0.001). The optimal cutoff for diagnosing HCC using the GALAD score was −0.518, achieving a sensitivity of 87.25%, specificity of 82.98%, positive predictive value of 84.62%, and negative predictive value of 84.78%. At this cutoff, the GALAD score demonstrated superior sensitivity compared with single or combined biomarkers. Conclusions: The GALAD score shows promise in detecting HCC in patients with cirrhosis. The GALAD score could be applied in clinical practice to diagnose HCC in patients with cirrhosis, and calculating the GALAD score in clinical settings may help predict tumor size and quantity before imaging results become available.

22 July 2025 in JGH Open
Verified
Journal Article
Open access
NVNhu Thi Hanh Vu
Nhu Thi Hanh Vu
Huong Tu LamHuong Tu Lam
Huong Tu Lam
SMShunsuke Miyauchi
Shunsuke Miyauchi
NINaoki Ishiuchi
Naoki Ishiuchi
AYAtsuo Yoshino
Atsuo Yoshino
THToru Hiyama
Toru Hiyama
Background and Aim: Chronic constipation (CC) is a prevalent gastrointestinal disorder in which individuals with more severe CC significantly decrease their quality of life and often require more active medical intervention. This study aimed to identify the rate and risk factors associated with moderate‐to‐severe CC among Japanese university students.Methods: A cross‐sectional study was conducted among university students diagnosed with CC according to the Rome IV criteria at Hiroshima University, Hiroshima, Japan. The online questionnaire collected data on demographics, lifestyle habits, family history of constipation, and psychological assessments via the Beck Depression Inventory, Eating Attitudes Test‐26, and Bulimic Investigatory Test. CC severity was classified based on the Bristol Stool Form Scale (BSFS), spontaneous bowel movements (SBM), and associated symptoms. Multivariate logistic regression analysis was performed to determine independent risk factors.Results: Among the 779 CC participants, 47% were classified as having moderate‐to‐severe CC. Independent risk factors associated with moderate‐to‐severe CC included age of CC onset < 18 years (OR: 1.374, 95% CI: 1.017–1.857), female sex (OR: 1.444, 95% CI: 1.058–1.969), family history of CC (OR: 1.449, 95% CI: 1.072–1.958), and sleep duration ≤ 6 h per day (OR: 1.350, 95% CI: 1.011–1.802).Conclusions: Moderate‐to‐severe CC was highly common among Japanese students with CC, and risk factors included early onset, female sex, family history of CC, and short sleep duration. These findings suggest that early diagnosis and development of management strategies may be needed to enhance the quality of life and health outcomes of affected individuals.

27 September 2023 in Case Reports in Critical Care
Verified
Journal Article
Open access
PDF file
Huong Tu LamHuong Tu Lam
Huong Tu Lam
TNThang Dinh Nguyen
Thang Dinh Nguyen
PHPhat Tan Ho
Phat Tan Ho
ANAi Van Nguyen
Ai Van Nguyen
TNTuan Huynh Nhat Nguyen
Tuan Huynh Nhat Nguyen
Thong Duy VoThong Duy Vo
Thong Duy Vo
Pseudoaneurysm rupture in patients with pancreatitis is a rare but fatal etiology of upper gastrointestinal bleeding. We report a rare case of upper gastrointestinal bleeding in a patient who presented simultaneously with two pseudoaneurysms, a potential cause of severe gastrointestinal bleeding. Angiography was successfully performed with coil embolization of the target arteries and both pseudoaneurysmal sacs. The patient was discharged 9 days after admission without further events within a 3-month follow-up period.